Cataflam Interactions
There are 442 drugs known to interact with Cataflam (diclofenac), along with 11 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 97 are major, 328 are moderate, and 17 are minor.
- View all 442 medications that may interact with Cataflam
- View Cataflam alcohol/food interactions (2)
- View Cataflam disease interactions (11)
Most frequently checked interactions
View interaction reports for Cataflam (diclofenac) and the medicines listed below.
- allopurinol
- amlodipine
- aspirin
- atorvastatin
- Augmentin (amoxicillin / clavulanate)
- Celebrex (celecoxib)
- clonazepam
- Cymbalta (duloxetine)
- Flexeril (cyclobenzaprine)
- gabapentin
- hydrochlorothiazide
- ibuprofen
- Lipitor (atorvastatin)
- lisinopril
- losartan
- Lyrica (pregabalin)
- metformin
- naproxen
- Neurontin (gabapentin)
- Nexium (esomeprazole)
- omeprazole
- Paracetamol (acetaminophen)
- prednisone
- Singulair (montelukast)
- Synthroid (levothyroxine)
- Topamax (topiramate)
- tramadol
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zoloft (sertraline)
Cataflam alcohol/food interactions
There are 2 alcohol/food interactions with Cataflam (diclofenac).
Cataflam disease interactions
There are 11 disease interactions with Cataflam (diclofenac) which include:
- asthma
- fluid retention
- GI toxicity
- rash
- renal toxicities
- thrombosis
- porphyria
- anemia
- hepatotoxicity
- hyperkalemia
- platelet aggregation inhibition
Report options
QR code containing a link to this page
More about Cataflam (diclofenac)
- Cataflam consumer information
- Compare alternatives
- Reviews (50)
- Drug images
- Latest FDA alerts (11)
- Side effects
- Dosage information
- During pregnancy
- Drug class: Nonsteroidal anti-inflammatory drugs
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
